Health Ministry issues advisory on use of Remdesivir for COV

A peer reviewed study titled Early Remdesivir to Prevent Progression to Severe Covid 19 in Outpatients found that patients who received a 3 day course of Remdesivir had an 87 per cent lower risk of Covid 19 related death

Related Keywords

, Union Health Ministry , New Delhi , Jagran News Desk , New England Journal , Early Remdesivir , Prevent Progression , Covid 19 , Remdesivir , Emdesivir Guidelines , Remdesivir Uses , Emdesivir Safety , Emdesivir Latest Guidelines , S Remdesivir Safe , Ow Safe Is Remdesivir , Emdesivir In Omicron ,